Ribbon Blender Model 42N-270 Increases Performance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ribbon Blender Model 42N-270 Increases Performance


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The Ribbon Blender Model 42N-270 has a maximum working capacity of 270 cu.ft. and a full holding capacity of 300 cu.ft. The stainless steel wetted parts are polished to 150-grit finish for cleanability. The gasketed three-piece cover, safety grating, and pneumatically-operated 10” knife gate valve are all designed to facilitate ingredient charging and dust-tight operation. The double ribbon agitator is fabricated to produce a well-balanced axial and radial flow of powders while holding tightly-controlled clearances between the trough. The solid agitator shaft is driven to 20 rpm by a 100 HP TEFC motor.  All Ross Ribbon Blenders are equipped with a direct drive gear motor for improved performance and lower maintenance. With Ross-supplied controls, users receive a production-ready blender and benefit from electronic speed control, soft-start capabilities, and overload protection without any wiring hassles.

Charles Ross & Son Company

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here